Atrial Fibrillation
Conditions
Brief summary
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
Interventions
DEVICECRM Device
Pacemaker, ICD, or CRT device
Sponsors
Abbott Medical Devices
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is implanted with a CRM device * Patient has no documented history of AF (3 months prior to enrollment) * Patient is \>18 years of age * Patient has life expectancy of \>24 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of atrial tachycardia and atrial fibrillation in a cardiac rhythm management population | 24 months |
Secondary
| Measure | Time frame |
|---|---|
| Development or exacerbation of HF | 2 years |
| Development of AF | 2 years |
| AT/AF burden | 2 years |
Countries
United States
Outcome results
None listed